Thomas B. (Brad) Gold, Ph.D.
Head, Global Formulations R&D

Piramal Pharma Solutions is proud to include Brad Gold as a member of our Science Collective. Brad has an outstanding legacy of scientific excellence built over 30+ years in the industry. As our Global Formulations R&D Head, Brad provides complete scientific oversight for Piramal’s drug product formulations business. He is an integral part of the operations at our formulation sites in the US, UK and India, and a valuable resource to all of our drug product customers.

Over the course of his career, Brad has established a proven track record of solving formulation and process challenges in pharmaceutical development, directing operations, containment design and implementation, continuous improvement, and people engagement.

Watch Brad’s Video

His Career Highlights Include:

  • Oversight of precommercial activities, including clinical trial manufacturing, at Catalent Pharma Solutions
  • Responsibility for all formulation and process development at Metrics Contract Services
  • Implementation of operational excellence modules together with reporting and tracking systems, application of lean principles, and quality by design
  • GMP compliance and audit support for the complete pharmaceutical development function
  • Evaluation and implementation of new technology platforms, including highly potent manufacturing capabilities

Brad’s biography:

  • MS in Chemistry and a PhD in Pharmaceutics & Medicinal Chemistry from the University of Kentucky
  • Holder of 5 industry patents related to sustained release, zero-order release, and near zero-order release formulations
  • Author or co-author of more than 20 published technical papers
  • In addition to being part of the Science Collective, Brad is also a member of the Piramal Pharma Solutions Client Advisory Board

Brad’s expertise is an asset that is available to all our clients, in person or via a virtual session. To arrange a meeting send an email to [email protected].

Piramal Pharma Solutions